Abstract:Parkinson's disease (PD) is a chronic progressive neurodegenerative disorder symptomatically characterized by resting tremor, rigidity, bradykinesia, and gait impairment. These motor deficits suffered by PD patients primarily result from selective dysfunction or loss of dopaminergic neurons of the substantia nigra pars compacta (SNpc). Most of the existing therapies for PD are based on the replacement of dopamine, which is symptomatically effective in the early stage but becomes increasingly less effective and is accompanied by serious side effects in the advanced stages of the disease. Currently, there are no strategies to slow neuronal degeneration or prevent the progression of PD. Thus, the prospect of regenerating functional dopaminergic neurons is very attractive. Over the last few decades, significant progress has been made in the development of dopaminergic regenerative strategies for curing PD. The most promising approach seems to be cell-replacement therapy (CRT) using human embryonic stem cells (ESCs) or induced pluripotent stem cells (iPSCs), which are unlimitedly available and have gained much success in preclinical trials. Despite the challenges, stem cell-based CRT will make significant steps toward the clinic in the coming decade. Alternatively, direct lineage reprogramming, especially in situ direct conversion of glia cells to induced neurons, which exhibits some advantages including no ethical concerns, no risk of tumor formation, and even no need for transplantation, has gained much attention recently. Evoking the endogenous regeneration ability of neural stem cells (NSCs) is an idyllic method of dopaminergic neuroregeneration which remains highly controversial. Here, we review many of these advances, highlighting areas and strategies that might be particularly suited to the development of regenerative approaches that restore dopaminergic function in PD.

Overcoming Methodological Challenges for Advancing Stem Cell Therapies in Parkinson's Disease

Current Status and Future Perspectives on Stem Cell-Based Therapies for Parkinson’s Disease

Stem Cell Therapy for the Treatment of Parkinson's Disease: What Promise Does it Hold?

Stem Cell Therapy for Parkinson's Disease

Advancing Parkinson's disease treatment: cell replacement therapy with neurons derived from pluripotent stem cells

Advancements in Autologous Stem Cell Transplantation for Parkinson's Disease

Cell therapy for Parkinson’s disease with induced pluripotent stem cells

Therapeutic application of stem cell technology toward the treatment of Parkinson's disease.

Pluripotent Stem Cell Therapies for Parkinson Disease: Present Challenges and Future Opportunities

Redefining Parkinson’s Disease Research Using Induced Pluripotent Stem Cells

Stem Cell-Based Approaches in Parkinson’s Disease Research

Ethical and Safety Considerations in Stem Cell-Based Therapy for Parkinson’s Disease

Research progress of neural stem cells as a source of dopaminergic neurons for cell therapy in Parkinson's disease

Cell Therapy for Parkinson's Disease

Defining the unknowns for cell therapies in Parkinson's disease

Efficacy and Efficacy-Influencing Factors of Stem Cell Transplantation on Patients with Parkinson’s Disease: a Systematic Review and Meta-Analysis

Clinical Considerations in Parkinson’s Disease Cell Therapy

Progress in Dopaminergic Cell Replacement and Regenerative Strategies for Parkinson's Disease.

Pluripotent stem cell-based therapy for Parkinson’s disease: Current status and future prospects

Cells therapy for Parkinson’s disease—so close and so far away

A Compendium of Preparation and Application of Stem Cells in Parkinson's Disease: Current Status and Future Prospects